BIOMAXIMA/ PLBIOMX00015 /
| 2024-05-02 5:02:52 PM | Chg. -0.70 | Volume | Bid9:10:00 PM | Ask9:10:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 14.30PLN | -4.67% | 4,200 Turnover: 59,320.05 |
-Bid Size: - | -Ask Size: - | 61.9 mill.PLN | 3.50% | 2.14 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 6.68 PLN | 181.86% |
| EPS Diluted: | - PLN | 182.97% |
| Revenues per Share: | 33.24 PLN | 81.55% |
| Book Value per Share: | 12.12 PLN | 79.33% |
| Cash Flow per Share: | 8.56 PLN | - |
| Dividend per Share: | 0.50 PLN | 11.11% |
| Total | in th. | |
| Revenues: | 143,867.00 PLN | 81.91% |
| Net Income: | 28,885.00 PLN | 182.00% |
| Operating Cash Flow: | 37,065.00 PLN | - |
| Cash and Cash Equivalents: | 12,907.00 PLN | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 2.14 | 3.85 |
| P/S Ratio: | 0.43 | 0.77 |
| P/BV ratio: | 1.18 | 2.12 |
| P/CF Ratio: | 1.67 | 3.00 |
| PEG: | 0.01 | 0.02 |
| Earnings Yield: | 46.71% | 25.99% |
| Dividend Yield: | 3.50% | 1.95% |
| Market Capitalization | ||
| Market Capitalization: | 61.9 mill. PLN | 111.24 mill. PLN |
| Free Float Market Cap.: | - PLN | - PLN |
| Market Cap. / Employee: | 507,356.9672 PLN | 911,823.3607 PLN |
| Shares Outstanding: | 4.33 mill. | |
Profitability
| Gross Profit Margin: | 45.98% |
| EBIT Margin: | 24.23% |
| Net Profit Margin: | 20.08% |
| Return on Equity: | 55.07% |
| Return on Assets: | 38.81% |
Financial Strength
| Liquidity I / Cash Ratio: | 117.58% |
| Liquidity II / Quick Ratio: | 199.53% |
| Liquidity III / Current Ratio: | 330.01% |
| Debt / Equity Ratio: | 41.87% |
| Dynam. Debt / Equity Ratio: | 59.26% |
Efficiency
| Employees: | 122 |
| Personal Expenses / Employee: | - PLN |
| Revenues / Employee: | 1,179,237.70 PLN |
| Net Income / Employee: | 236,762.30 PLN |
| Total Assets / Employee: | 610,008.20 PLN |
| * Fiscal Year End: | 2022-12-31 |
| Accounting Standard: | IFRS |
| Currency: | PLN |
